Vortex-assisted  	Vortex-assisted  	 JJ	O
liquid-liquid  	liquid-liquid  	 JJ	B-NP
extraction  	extraction  	 NNS	I-NP
combined  	combined  	 VBN	O
with  	with  	 IN	O
field-amplified  	field-amplified  	 JJ	O
sample  	sample  	 NN	B-NP
injection  	injection  	 NN	I-NP
and  	and  	 CC	O
sweeping  	sweeping  	 JJ	O
micellar  	micellar  	 JJ	B-NP
electrokinetic  	electrokinetic  	 JJ	I-NP
chromatography  	chromatography  	 NN	I-NP
for  	for  	 IN	O
improved  	improved  	 JJ	O
determination  	determination  	 NN	B-NP
of  	of  	 IN	I-NP
β-blockers  	β-blockers  	 JJ	I-NP
in  	in  	 IN	O
human  	human  	 JJ	O
urine  	urine  	 NNS	O
A  	A  	 DT	O
new  	new  	 JJ	O
micellar  	micellar  	 FW	B-NP
electrokinetic  	electrokinetic  	 FW	I-NP
chromatography  	chromatography  	 FW	I-NP
( 	( 	 -LRB-	O
MEKC 	MEKC 	 NNP	B-NP
)  	)  	 -RRB-	O
method  	method  	 NN	O
was  	was  	 VBD	O
developed  	developed  	 VBN	O
and  	and  	 CC	O
validated  	validated  	 NN	O
for  	for  	 IN	O
the  	the  	 DT	O
analysis  	analysis  	 NN	O
of  	of  	 IN	O
carvedilol  	carvedilol  	 NN	B-NP
and  	and  	 CC	O
propranolol  	propranolol  	 NN	B-NP
in  	in  	 IN	O
human  	human  	 JJ	O
urine  	urine  	 NN	O
samples 	samples 	 NNS	O
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
study 	study 	 NN	O
,  	,  	 ,	O
vortex-assisted  	vortex-assisted  	 JJ	B-NP
liquid-liquid  	liquid-liquid  	 JJ	I-NP
extraction  	extraction  	 NNS	I-NP
( 	( 	 -LRB-	O
VALLE 	VALLE 	 NNP	B-NP
)  	)  	 -RRB-	O
coupled  	coupled  	 VBN	O
with  	with  	 IN	O
field-amplified  	field-amplified  	 JJ	O
sample  	sample  	 NN	B-NP
injection  	injection  	 NN	I-NP
and  	and  	 CC	O
sweeping  	sweeping  	 JJ	O
was  	was  	 VBD	O
employed  	employed  	 VBN	O
for  	for  	 IN	O
biological  	biological  	 JJ	B-NP
sample  	sample  	 NN	I-NP
clean-up  	clean-up  	 JJ	I-NP
and  	and  	 CC	O
sensitivity  	sensitivity  	 JJ	B-NP
enhancement  	enhancement  	 NN	I-NP
in  	in  	 IN	O
MEKC 	MEKC 	 NNP	B-NP
.  	.  	 .	O
After  	After  	 IN	O
VALLE 	VALLE 	 NNP	B-NP
,  	,  	 ,	O
the  	the  	 DT	O
urine  	urine  	 JJ	O
samples  	samples  	 NNS	O
were  	were  	 VBD	O
analyzed  	analyzed  	 VBN	O
by  	by  	 IN	O
MEKC 	MEKC 	 NNP	B-NP
.  	.  	 .	O
Tris-phosphate  	Tris-phosphate  	 JJ	B-NP
buffer  	buffer  	 NN	I-NP
( 	( 	 -LRB-	O
60mmolL 	60mmolL 	 NNP	B-NP
( 	( 	 -LRB-	I-NP
-1 	-1 	 NNP	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
pH  	pH  	 JJ	O
2.0 	2.0 	 CD	O
)  	)  	 -RRB-	O
containing  	containing  	 VBG	O
40 	40 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
v 	v 	 FW	B-NP
/ 	/ 	 FW	I-NP
v 	v 	 FW	I-NP
)  	)  	 -RRB-	O
methanol  	methanol  	 NN	O
was  	was  	 VBD	O
first  	first  	 RB	O
filled  	filled  	 VBN	O
into  	into  	 IN	O
an  	an  	 DT	O
uncoated  	uncoated  	 JJ	B-NP
fused-silica  	fused-silica  	 JJ	I-NP
capillary  	capillary  	 NNS	I-NP
( 	( 	 -LRB-	O
56cm 	56cm 	 NNP	O
,  	,  	 ,	O
50µm  	50µm  	 CD	O
i.d. 	i.d. 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
pretreated  	pretreated  	 JJ	B-NP
urine  	urine  	 JJ	I-NP
sample  	sample  	 NN	I-NP
was  	was  	 VBD	O
loaded  	loaded  	 VBN	O
by  	by  	 IN	O
electrokinetic  	electrokinetic  	 JJ	B-NP
injection  	injection  	 NN	I-NP
( 	( 	 -LRB-	O
10kV 	10kV 	 NNP	O
,  	,  	 ,	O
250s 	250s 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
The  	The  	 DT	O
stacking  	stacking  	 NN	O
and  	and  	 CC	O
separation  	separation  	 NN	O
were  	were  	 VBD	O
performed  	performed  	 VBN	O
using  	using  	 VBG	O
Tris-phosphate  	Tris-phosphate  	 JJ	B-NP
buffer  	buffer  	 NN	I-NP
( 	( 	 -LRB-	O
30mmolL 	30mmolL 	 NNP	B-NP
( 	( 	 -LRB-	I-NP
-1 	-1 	 NNP	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
pH  	pH  	 JJ	O
3.0 	3.0 	 CD	O
)  	)  	 -RRB-	O
containing  	containing  	 VBG	O
30 	30 	 CD	O
%  	%  	 NN	O
( 	( 	 -LRB-	O
v 	v 	 FW	B-NP
/ 	/ 	 FW	I-NP
v 	v 	 FW	I-NP
)  	)  	 -RRB-	O
methanol  	methanol  	 NN	O
and  	and  	 CC	O
50mmolL 	50mmolL 	 NNP	B-NP
( 	( 	 -LRB-	I-NP
-1 	-1 	 NNP	I-NP
)  	)  	 -RRB-	I-NP
sodium  	sodium  	 FW	I-NP
dodecyl  	dodecyl  	 FW	I-NP
sulfate  	sulfate  	 FW	I-NP
( 	( 	 -LRB-	O
SDS 	SDS 	 NNP	B-NP
)  	)  	 -RRB-	O
at  	at  	 IN	O
-25kV 	-25kV 	 CD	O
.  	.  	 .	O
Detection  	Detection  	 NNP	O
was  	was  	 VBD	O
carried  	carried  	 VBN	O
out  	out  	 RP	O
at  	at  	 IN	O
195  	195  	 CD	O
and  	and  	 CC	O
214nm  	214nm  	 CD	O
for  	for  	 IN	O
carvedilol  	carvedilol  	 NN	B-NP
and  	and  	 CC	O
propranolol 	propranolol 	 NN	B-NP
,  	,  	 ,	O
respectively 	respectively 	 RB	O
.  	.  	 .	O
The  	The  	 DT	O
suggested  	suggested  	 JJ	O
method  	method  	 NN	O
is  	is  	 VBZ	O
linear  	linear  	 JJ	O
( 	( 	 -LRB-	O
r 	r 	 LS	B-NP
( 	( 	 -LRB-	I-NP
2 	2 	 LS	I-NP
) 	) 	 -RRB-	O
≥0.997 	≥0.997 	 CD	O
)  	)  	 -RRB-	O
over  	over  	 IN	O
a  	a  	 DT	O
dynamic  	dynamic  	 JJ	B-NP
range  	range  	 NN	I-NP
of  	of  	 IN	O
0.005-1µgmL 	0.005-1µgmL 	 NNP	O
( 	( 	 -LRB-	O
-1 	-1 	 NNP	O
)  	)  	 -RRB-	O
in  	in  	 IN	O
urine 	urine 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
intra-  	intra-  	 JJ	O
and  	and  	 CC	O
inter-day  	inter-day  	 JJ	B-NP
relative  	relative  	 JJ	I-NP
standard  	standard  	 JJ	I-NP
deviation  	deviation  	 NN	I-NP
and  	and  	 CC	O
relative  	relative  	 JJ	B-NP
error  	error  	 NN	I-NP
values  	values  	 NNS	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
method  	method  	 NN	O
were  	were  	 VBD	O
below  	below  	 IN	O
20 	20 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
which  	which  	 WDT	O
shows  	shows  	 VBZ	O
good  	good  	 JJ	O
precision  	precision  	 NN	O
and  	and  	 CC	O
accuracy 	accuracy 	 NN	B-NP
.  	.  	 .	O
Finally 	Finally 	 RB	O
,  	,  	 ,	O
this  	this  	 DT	O
method  	method  	 NN	O
was  	was  	 VBD	O
successfully  	successfully  	 RB	O
applied  	applied  	 VBN	O
to  	to  	 TO	O
the  	the  	 DT	O
analysis  	analysis  	 NN	O
of  	of  	 IN	O
real  	real  	 JJ	O
urine  	urine  	 NN	O
samples 	samples 	 NNS	O
.  	.  	 .	O
